The company aims to increase its expense in biotechnology and biosimilars, targeting an approximate market place price of USD twenty five billion in India by 2025. Wockhardt's initiatives to scale up production capabilities are evident, with strategies to enhance generation capability by thirty% more than the following two a long https://bookmarksfocus.com/story5731656/the-single-best-strategy-to-use-for-codeine-syrup